(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate; SMS 201-995ac; Sandostatin; Sandostatin LAR
Octreotide Acetate is a fully characterized chemical compound used as a reference standard of API Octreotide. The standard offered is compliant with regulatory guidelines. Octreotide Acetate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 79517-01-4
Related products
Octreotide-phenylalanine-d8 di-Trifluoroacetic Acid Salt
M.F.
M.W. 1027.31 2x114.02
CAT# AR-O01045
CAS# N/A
Octreotide Non-Cyclic System Suitability Marker TFA Salt
M.F.
M.W. 1092.34 : 114.02
CAT# AR-O08866
CAS# NA